Abstract
Conventional cytotoxic chemotherapy is not usually effective in neuroendocrine tumours (NET). Somatostatin analogues (SSA) such as octreotide (Sandostatin; octreotide LAR and lanreotide) are typically used to treat symptoms caused by NET, but not as the primary treatment aiming for an objective response. Recently, results from the PROMID (Placebo-controlled prospective Randomized study on the antiproliferative efficacy of Octreotide LAR in patients with metastatic neuroendocrine MIDgut tumours) trial were published showing that octreotide LAR significantly lengthens the time to tumour progression compared with a placebo in patients with functionally active and inactive metastatic midgut NET. We report a retrospective descriptive analysis of six patients, treated at two Australian institutions, who obtained an objective radiological tumour response on long acting SSA. In this retrospective series of NET, radiological responses were observed using single agent SSA, which was administered mainly for symptom management. This could be due to an antiproliferative and/or antiangiogenic activity of this agent in NET. A response can occur beyond 12 months, which might explain why the response rate is under reported in NET trials. Furthe...Continue Reading
References
May 1, 1992·American Journal of Surgery·H HajarizadehE A Woltering
Oct 1, 1994·Clinical Endocrinology·L FredstorpK Hall
Jan 1, 1993·Acta Oncologica·L AnthonyJ Oates
May 1, 1995·American Journal of Surgery·D S DiacoE A Woltering
Jul 1, 1993·World Journal of Surgery·R ArnoldC Bruns
Jan 15, 1996·Cancer·M di BartolomeoA di Leo
Mar 1, 1996·Gut·R ArnoldH J Dennler
Dec 24, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B ErikssonK Oberg
Jul 10, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Eriksson, K Oberg
Feb 3, 2000·Journal of the National Cancer Institute·P TherasseS G Gwyther
Jan 13, 2001·Clinical Endocrinology·K E ImtiazA Khaleeli
Mar 1, 2002·Journal of Surgical Oncology·Wey L Leong, Janice L Pasieka
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Siegbert FaissUNKNOWN International Lanreotide and Interferon Alfa Study Group
Oct 20, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Rudolf ArnoldChristian N Arnold
Jul 11, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Carl Jaffe
Jul 27, 2007·Acta Oncologica·Martijn Van EssenDik J Kwekkeboom
Jan 8, 2008·The Lancet Oncology·Irvin M ModlinAnders Sundin
Aug 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anja RinkeUNKNOWN PROMID Study Group
Citations
Sep 3, 2010·Der Pathologe·H SasanoA Kasajima
Jan 26, 2016·Expert Review of Anticancer Therapy·Mustafa KhasrawMichael Michael
Sep 1, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ina RosenbergerJörg Kreuter
Apr 9, 2013·Expert Review of Anticancer Therapy·Mustafa KhasrawSumitra Ananda